Pucelik Barbara, Arnaut Luis G, Dąbrowski Janusz M
Faculty of Chemistry, Jagiellonian University, 30-387 Kraków, Poland.
Malopolska Centre of Biotechnology, Jagiellonian University, 30-387 Kraków, Poland.
J Clin Med. 2019 Dec 19;9(1):8. doi: 10.3390/jcm9010008.
Photodynamic therapy (PDT) augments the host antitumor immune response, but the role of the PDT effect on the tumor microenvironment in dependence on the type of photosensitizer and/or therapeutic protocols has not been clearly elucidated. We employed three bacteriochlorins (FBOH, FBMet and ClBHep) of different polarity that absorb near-infrared light (NIR) and generated a large amount of reactive oxygen species (ROS) to compare the PDT efficacy after various drug-to-light intervals: 15 min. (V-PDT), 3h (E-PDT) and 72h (C-PDT). We also performed the analysis of the molecular mechanisms of PDT crucial for the generation of the long-lasting antitumor immune response. PDT-induced damage affected the integrity of the host tissue and developed acute (protocol-dependent) local inflammation, which in turn led to the infiltration of neutrophils and macrophages. In order to further confirm this hypothesis, a number of proteins in the plasma of PDT-treated mice were identified. Among a wide range of cytokines (IL-6, IL-10, IL-13, IL-15, TNF-α, GM-CSF), chemokines (KC, MCP-1, MIP1α, MIP1β, MIP2) and growth factors (VEGF) released after PDT, an important role was assigned to IL-6. PDT protocols optimized for studied bacteriochlorins led to a significant increase in the survival rate of BALB/c mice bearing CT26 tumors, but each photosensitizer (PS) was more or less potent, depending on the applied DLI (15 min, 3 h or 72 h). Hydrophilic (FBOH) and amphiphilic (FBMet) PSs were equally effective in V-PDT (>80 cure rate). FBMet was the most efficient in E-PDT (DLI = 3h), leading to a cure of 65 % of the animals. Finally, the most powerful PS in the C-PDT (DLI = 72 h) regimen turned out to be the most hydrophobic compound (ClBHep), allowing 100 % of treated animals to be cured at a light dose of only 45 J/cm.
光动力疗法(PDT)可增强宿主抗肿瘤免疫反应,但PDT效应在肿瘤微环境中对光敏剂类型和/或治疗方案的依赖性尚未得到明确阐释。我们使用了三种极性不同、吸收近红外光(NIR)并能产生大量活性氧(ROS)的细菌叶绿素(FBOH、FBMet和ClBHep),比较了不同药物与光照间隔(15分钟(V-PDT)、3小时(E-PDT)和72小时(C-PDT))后的PDT疗效。我们还对PDT产生持久抗肿瘤免疫反应的关键分子机制进行了分析。PDT诱导的损伤影响宿主组织的完整性,并引发急性(方案依赖性)局部炎症,进而导致中性粒细胞和巨噬细胞浸润。为了进一步证实这一假设,我们鉴定了PDT处理小鼠血浆中的多种蛋白质。在PDT后释放的多种细胞因子(IL-6、IL-10、IL-13、IL-15、TNF-α、GM-CSF)、趋化因子(KC、MCP-1、MIP1α、MIP1β、MIP2)和生长因子(VEGF)中,IL-6被认为发挥了重要作用。针对所研究细菌叶绿素优化的PDT方案导致携带CT26肿瘤的BALB/c小鼠存活率显著提高,但每种光敏剂(PS)的效力或多或少有所不同,这取决于所应用的药物光照间隔(15分钟、3小时或72小时)。亲水性(FBOH)和两亲性(FBMet)PS在V-PDT中同样有效(治愈率>80%)。FBMet在E-PDT(药物光照间隔=3小时)中效率最高,使65%的动物得到治愈。最后,在C-PDT(药物光照间隔=72小时)方案中最有效的PS是疏水性最强的化合物(ClBHep),在仅45 J/cm的光照剂量下可使100%的治疗动物得到治愈。